HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

hexabrominated diphenyl ether 153

structure in first source

Also Known As:

2,2',4,4',5,5'-brominated diphenyl ether; BDE-153

Networked: 15 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Biphenyl Compounds: 7
        Polybrominated Biphenyls: 44
        hexabrominated diphenyl ether 153: 15
  - Halogenated Hydrocarbons: 42
    - Brominated Hydrocarbons: 1
      - Polybrominated Biphenyls: 44
        hexabrominated diphenyl ether 153: 15

Experts

1.	Li, Xin: 2 articles (07/2013 - 06/2013)
2.	Niu, Qiao: 2 articles (07/2013 - 06/2013)
3.	Chen, Jiazhang: 1 article (11/2020)
4.	Chen, Xi: 1 article (11/2020)
5.	Gyimah, Eric: 1 article (11/2020)
6.	Meng, Shunlong: 1 article (11/2020)
7.	Xu, Hai: 1 article (11/2020)
8.	Antignac, Jean-Philippe: 1 article (01/2020)
9.	Arveux, Patrick: 1 article (01/2020)
10.	Boutron-Ruault, Marie-Christine: 1 article (01/2020)

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 01/01/2020 - "The analysis showed a non-linear inverse association for BDE-100 and BDE-153 and postmenopausal breast cancer risk; nevertheless, these findings were statistically significant only when the exposure was modeled as ng/L plasma (third vs. first quintile: OR = 0.42, 95%CI = 0.19-0.93 and OR = 0.42, 95%CI = 0.18-0.98, respectively) and not when modeled as ng/gr of lipids (OR = 0.58, 95%CI = 0.27-1.25 and OR = 0.53, 95%CI = 0.25-1.17). " 01/01/2019 - "Our findings provide no evidence that serum levels of BDE-47, BDE-100 or BDE-153 are associated with breast cancer risk. " 11/01/2018 - "In the adjusted univariate model for all cases, breast cancer risk was increased with both 2nd and 3rd tertiles versus the 1st tertile of BDE-47 level (OR 2.05 [95% CI 1.08-3.92]; 5.47 [2.96-10.11]) and BDE-209 level (2.48 [1.30-4.73]; 4.72 [2.52-8.83]) with trend (both P < 0.001) and with the 3rd tertile of BDE-28 level (2.83 [1.63-4.92]), BDE-99 (3.22 [1.85-5.60]), BDE-100 (5.45 [2.90-10.23]), BDE-138 (2.40 [1.37-4.20]), BDE-153 (1.74 [1.02-2.97]), BDE-154 (1.84 [1.05-3.22]), and ∑PBDE levels (1.83 [1.07-3.14]) but decreased with the 3rd tertile of BDE-71 level (0.38 [0.22-0.65]) with trend (all P < 0.01). "
2.	Body Weight (Weight, Body) 01/01/2023 - "After BDE-153 exposure, the weight of mice in the medium-high-dose group at different exposure times was lower than that in the control group ( p all <0.05), and the body weight decreased slightly with the increase of the dose of BDE-153. " 06/23/2013 - "At postnatal day 10 (PND10), the pups in the BDE-153 groups were intraperitoneally injected once with BDE-153 plant oil solutions at 0.1ml/10g body weight, and the controls were injected with plant oil. " 07/01/2013 - "Forty newborn male rats were randomly and equally divided into four groups according to their body weights and litters: 1, 5, and 10 mg/kg BDE-153 groups and olive oil solvent control group. " 07/01/2013 - "On postnatal day 10 (PND 10), the BDE-153 groups were administrated BDE-153 (0.1 ml/10 g body weight) by intraperitoneal injection, while the olive oil solvent control group was given an equal volume of olive oil. "
3.	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/01/2019 - "All childhood BDE-153 concentrations were inversely associated with reading scores at 5 and 8 years, but associations were not statistically significant after covariate adjustment. "
4.	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/01/2023 - "Our results suggest that BDE-153 may interfere with the expression of adipokines and the secretion of insulin by affecting the expression of PPARγ and AMPKα, which play a key role in glucose and lipid metabolism, leading to the occurrence of glucose and lipid metabolism disorder."
5.	Premature Birth (Birth, Premature) 12/01/2016 - "BDE-153 was associated with an increased risk of premature birth (adjusted OR [95% CI]:1.05 [1.01, 1.09]), and BDE-28 was associated with longer time to pregnancy (adjusted OR [95% CI]: 1.34 [1.03, 1.76]). "

Related Drugs and Biologics

1.	2,2',4,4'-tetrabromodiphenyl ether
2.	pentabrominated diphenyl ether 100
3.	2,2',4,4',5-brominated diphenyl ether
4.	tribromodiphenyl ether 28
5.	Lipids
6.	hexabromodiphenyl ether 154
7.	pentabromodiphenyl ether (PBDE)
8.	Halogenated Diphenyl Ethers
9.	Adipokines
10.	bcl-2-Associated X Protein (bcl 2 Associated X Protein)

Related Therapies and Procedures

1.	Intraperitoneal Injections